A detailed history of Black Rock Inc. transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Black Rock Inc. holds 7,060,208 shares of EBS stock, worth $48.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,060,208
Previous 9,399,197 24.88%
Holding current value
$48.6 Million
Previous $22.6 Million 20.82%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$1.5 - $3.41 $3.51 Million - $7.98 Million
-2,338,989 Reduced 24.88%
7,060,208 $17.9 Million
Q4 2023

Feb 13, 2024

BUY
$1.82 - $3.16 $1.75 Million - $3.04 Million
963,517 Added 11.42%
9,399,197 $22.6 Million
Q3 2023

Nov 13, 2023

SELL
$3.17 - $7.91 $2.52 Million - $6.3 Million
-796,048 Reduced 8.62%
8,435,680 $28.7 Million
Q2 2023

Aug 11, 2023

SELL
$7.35 - $13.21 $195,914 - $352,112
-26,655 Reduced 0.29%
9,231,728 $67.9 Million
Q1 2023

May 12, 2023

BUY
$7.79 - $16.29 $2.36 Million - $4.94 Million
303,165 Added 3.39%
9,258,383 $95.9 Million
Q4 2022

Feb 13, 2023

BUY
$11.0 - $21.45 $6.17 Million - $12 Million
561,216 Added 6.69%
8,955,218 $106 Million
Q3 2022

Nov 14, 2022

SELL
$20.09 - $35.8 $2.79 Million - $4.97 Million
-138,835 Reduced 1.63%
8,394,002 $176 Million
Q2 2022

Aug 12, 2022

SELL
$27.42 - $43.63 $5.46 Million - $8.69 Million
-199,067 Reduced 2.28%
8,532,837 $265 Million
Q1 2022

May 12, 2022

BUY
$36.48 - $52.22 $23.9 Million - $34.2 Million
655,003 Added 8.11%
8,731,904 $359 Million
Q4 2021

Feb 10, 2022

BUY
$33.11 - $55.01 $74.5 Million - $124 Million
2,249,296 Added 38.6%
8,076,901 $351 Million
Q3 2021

Nov 09, 2021

SELL
$50.07 - $66.05 $560,032 - $738,769
-11,185 Reduced 0.19%
5,827,605 $292 Million
Q2 2021

Aug 11, 2021

BUY
$56.61 - $80.46 $331 Million - $470 Million
5,838,790 New
5,838,790 $368 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $344M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.